Table of Content

1 Peramivir Market Overview
1.1 Product Overview and Scope of Peramivir
1.2 Peramivir Segment by Type
1.2.1 Global Peramivir Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Solution
1.2.3 Solid
1.3 Peramivir Segment by Application
1.3.1 Peramivir Sales Comparison by Application: (2021-2027)
1.3.2 Influenza A Treatment
1.3.3 Influenza B Treatment
1.4 Global Peramivir Market Size Estimates and Forecasts
1.4.1 Global Peramivir Revenue 2016-2027
1.4.2 Global Peramivir Sales 2016-2027
1.4.3 Peramivir Market Size by Region: 2016 Versus 2021 Versus 2027

2 Peramivir Market Competition by Manufacturers
2.1 Global Peramivir Sales Market Share by Manufacturers (2016-2021)
2.2 Global Peramivir Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Peramivir Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Peramivir Manufacturing Sites, Area Served, Product Type
2.5 Peramivir Market Competitive Situation and Trends
2.5.1 Peramivir Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Peramivir Players Market Share by Revenue
2.5.3 Global Peramivir Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Peramivir Retrospective Market Scenario by Region
3.1 Global Peramivir Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Peramivir Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Peramivir Market Facts & Figures by Country
3.3.1 North America Peramivir Sales by Country
3.3.2 North America Peramivir Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Peramivir Market Facts & Figures by Country
3.4.1 Europe Peramivir Sales by Country
3.4.2 Europe Peramivir Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Peramivir Market Facts & Figures by Region
3.5.1 Asia Pacific Peramivir Sales by Region
3.5.2 Asia Pacific Peramivir Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Peramivir Market Facts & Figures by Country
3.6.1 Latin America Peramivir Sales by Country
3.6.2 Latin America Peramivir Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Peramivir Market Facts & Figures by Country
3.7.1 Middle East and Africa Peramivir Sales by Country
3.7.2 Middle East and Africa Peramivir Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Peramivir Historic Market Analysis by Type
4.1 Global Peramivir Sales Market Share by Type (2016-2021)
4.2 Global Peramivir Revenue Market Share by Type (2016-2021)
4.3 Global Peramivir Price by Type (2016-2021)

5 Global Peramivir Historic Market Analysis by Application
5.1 Global Peramivir Sales Market Share by Application (2016-2021)
5.2 Global Peramivir Revenue Market Share by Application (2016-2021)
5.3 Global Peramivir Price by Application (2016-2021)

6 Key Companies Profiled
6.1 BioCryst Pharmaceuticals
6.1.1 BioCryst Pharmaceuticals Corporation Information
6.1.2 BioCryst Pharmaceuticals Description and Business Overview
6.1.3 BioCryst Pharmaceuticals Peramivir Sales, Revenue and Gross Margin (2016-2021)
6.1.4 BioCryst Pharmaceuticals Product Portfolio
6.1.5 BioCryst Pharmaceuticals Recent Developments/Updates
6.2 Green Cross Pharma
6.2.1 Green Cross Pharma Corporation Information
6.2.2 Green Cross Pharma Description and Business Overview
6.2.3 Green Cross Pharma Peramivir Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Green Cross Pharma Product Portfolio
6.2.5 Green Cross Pharma Recent Developments/Updates
6.3 Shionogi Co.
6.3.1 Shionogi Co. Corporation Information
6.3.2 Shionogi Co. Description and Business Overview
6.3.3 Shionogi Co. Peramivir Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Shionogi Co. Product Portfolio
6.3.5 Shionogi Co. Recent Developments/Updates
6.4 NeoPharm
6.4.1 NeoPharm Corporation Information
6.4.2 NeoPharm Description and Business Overview
6.4.3 NeoPharm Peramivir Sales, Revenue and Gross Margin (2016-2021)
6.4.4 NeoPharm Product Portfolio
6.4.5 NeoPharm Recent Developments/Updates
6.5 Moksha8 Pharma
6.5.1 Moksha8 Pharma Corporation Information
6.5.2 Moksha8 Pharma Description and Business Overview
6.5.3 Moksha8 Pharma Peramivir Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Moksha8 Pharma Product Portfolio
6.5.5 Moksha8 Pharma Recent Developments/Updates
6.6 NT Pharma
6.6.1 NT Pharma Corporation Information
6.6.2 NT Pharma Description and Business Overview
6.6.3 NT Pharma Peramivir Sales, Revenue and Gross Margin (2016-2021)
6.6.4 NT Pharma Product Portfolio
6.6.5 NT Pharma Recent Developments/Updates
6.7 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Peramivir Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Merck Product Portfolio
6.7.5 Merck Recent Developments/Updates
6.8 Hikma Pharmaceuticals
6.8.1 Hikma Pharmaceuticals Corporation Information
6.8.2 Hikma Pharmaceuticals Description and Business Overview
6.8.3 Hikma Pharmaceuticals Peramivir Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Hikma Pharmaceuticals Product Portfolio
6.8.5 Hikma Pharmaceuticals Recent Developments/Updates
6.9 Hunan Nucien Pharmaceutical Co., Ltd.
6.9.1 Hunan Nucien Pharmaceutical Co., Ltd. Corporation Information
6.9.2 Hunan Nucien Pharmaceutical Co., Ltd. Description and Business Overview
6.9.3 Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Hunan Nucien Pharmaceutical Co., Ltd. Product Portfolio
6.9.5 Hunan Nucien Pharmaceutical Co., Ltd. Recent Developments/Updates
6.10 SCOLR Pharma
6.10.1 SCOLR Pharma Corporation Information
6.10.2 SCOLR Pharma Description and Business Overview
6.10.3 SCOLR Pharma Peramivir Sales, Revenue and Gross Margin (2016-2021)
6.10.4 SCOLR Pharma Product Portfolio
6.10.5 SCOLR Pharma Recent Developments/Updates

7 Peramivir Manufacturing Cost Analysis
7.1 Peramivir Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Peramivir
7.4 Peramivir Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Peramivir Distributors List
8.3 Peramivir Customers

9 Peramivir Market Dynamics
9.1 Peramivir Industry Trends
9.2 Peramivir Growth Drivers
9.3 Peramivir Market Challenges
9.4 Peramivir Market Restraints

10 Global Market Forecast
10.1 Peramivir Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Peramivir by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Peramivir by Type (2022-2027)
10.2 Peramivir Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Peramivir by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Peramivir by Application (2022-2027)
10.3 Peramivir Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Peramivir by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Peramivir by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Peramivir Sales (Kilotons) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Peramivir Sales (Kilotons) Comparison by Application (2021-2027)
Table 3. Global Peramivir Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Peramivir Covered in This Study
Table 5. Global Peramivir Sales (Kilotons) of Key Manufacturers (2016-2021)
Table 6. Global Peramivir Sales Share by Manufacturers (2016-2021)
Table 7. Global Peramivir Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Peramivir Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Peramivir Average Price (US$/Kg) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Peramivir Manufacturing Sites and Area Served
Table 11. Manufacturers Peramivir Product Type
Table 12. Global Peramivir Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Peramivir by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peramivir as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Peramivir Sales by Region (2016-2021) & (Kilotons)
Table 16. Global Peramivir Sales Market Share by Region (2016-2021)
Table 17. Global Peramivir Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Peramivir Sales by Country (2016-2021) & (Kilotons)
Table 19. North America Peramivir Sales Market Share by Country (2016-2021)
Table 20. North America Peramivir Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Peramivir Revenue Market Share by Country (2016-2021)
Table 22. Europe Peramivir Sales by Country (2016-2021) & (Kilotons)
Table 23. Europe Peramivir Sales Market Share by Country (2016-2021)
Table 24. Europe Peramivir Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Peramivir Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Peramivir Sales by Region (2016-2021) & (Kilotons)
Table 27. Asia Pacific Peramivir Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Peramivir Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Peramivir Revenue Market Share by Region (2016-2021)
Table 30. Latin America Peramivir Sales by Country (2016-2021) & (Kilotons)
Table 31. Latin America Peramivir Sales Market Share by Country (2016-2021)
Table 32. Latin America Peramivir Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Peramivir Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Peramivir Sales by Country (2016-2021) & (Kilotons)
Table 35. Middle East and Africa Peramivir Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Peramivir Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Peramivir Revenue Market Share by Country (2016-2021)
Table 38. Global Peramivir Sales (Kilotons) by Type (2016-2021)
Table 39. Global Peramivir Sales Market Share by Type (2016-2021)
Table 40. Global Peramivir Revenue (Million US$) by Type (2016-2021)
Table 41. Global Peramivir Revenue Share by Type (2016-2021)
Table 42. Global Peramivir Price (US$/Kg) by Type (2016-2021)
Table 43. Global Peramivir Sales (Kilotons) by Application (2016-2021)
Table 44. Global Peramivir Sales Market Share by Application (2016-2021)
Table 45. Global Peramivir Revenue (Million US$) by Application (2016-2021)
Table 46. Global Peramivir Revenue Share by Application (2016-2021)
Table 47. Global Peramivir Price (US$/Kg) by Application (2016-2021)
Table 48. BioCryst Pharmaceuticals Corporation Information
Table 49. BioCryst Pharmaceuticals Description and Business Overview
Table 50. BioCryst Pharmaceuticals Peramivir Sales (Kilotons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 51. BioCryst Pharmaceuticals Peramivir Product
Table 52. BioCryst Pharmaceuticals Recent Developments/Updates
Table 53. Green Cross Pharma Corporation Information
Table 54. Green Cross Pharma Description and Business Overview
Table 55. Green Cross Pharma Peramivir Sales (Kilotons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 56. Green Cross Pharma Peramivir Product
Table 57. Green Cross Pharma Recent Developments/Updates
Table 58. Shionogi Co. Corporation Information
Table 59. Shionogi Co. Description and Business Overview
Table 60. Shionogi Co. Peramivir Sales (Kilotons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 61. Shionogi Co. Peramivir Product
Table 62. Shionogi Co. Recent Developments/Updates
Table 63. NeoPharm Corporation Information
Table 64. NeoPharm Description and Business Overview
Table 65. NeoPharm Peramivir Sales (Kilotons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 66. NeoPharm Peramivir Product
Table 67. NeoPharm Recent Developments/Updates
Table 68. Moksha8 Pharma Corporation Information
Table 69. Moksha8 Pharma Description and Business Overview
Table 70. Moksha8 Pharma Peramivir Sales (Kilotons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 71. Moksha8 Pharma Peramivir Product
Table 72. Moksha8 Pharma Recent Developments/Updates
Table 73. NT Pharma Corporation Information
Table 74. NT Pharma Description and Business Overview
Table 75. NT Pharma Peramivir Sales (Kilotons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 76. NT Pharma Peramivir Product
Table 77. NT Pharma Recent Developments/Updates
Table 78. Merck Corporation Information
Table 79. Merck Description and Business Overview
Table 80. Merck Peramivir Sales (Kilotons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 81. Merck Peramivir Product
Table 82. Merck Recent Developments/Updates
Table 83. Hikma Pharmaceuticals Corporation Information
Table 84. Hikma Pharmaceuticals Description and Business Overview
Table 85. Hikma Pharmaceuticals Peramivir Sales (Kilotons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 86. Hikma Pharmaceuticals Peramivir Product
Table 87. Hikma Pharmaceuticals Recent Developments/Updates
Table 88. Hunan Nucien Pharmaceutical Co., Ltd. Corporation Information
Table 89. Hunan Nucien Pharmaceutical Co., Ltd. Description and Business Overview
Table 90. Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Sales (Kilotons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 91. Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Product
Table 92. Hunan Nucien Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 93. SCOLR Pharma Corporation Information
Table 94. SCOLR Pharma Description and Business Overview
Table 95. SCOLR Pharma Peramivir Sales (Kilotons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 96. SCOLR Pharma Peramivir Product
Table 97. SCOLR Pharma Recent Developments/Updates
Table 98. Production Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Peramivir Distributors List
Table 101. Peramivir Customers List
Table 102. Peramivir Market Trends
Table 103. Peramivir Growth Drivers
Table 104. Peramivir Market Restraints
Table 105. Global Peramivir Sales Forecast by Type (2022-2027) & (Kilotons)
Table 106. Global Peramivir Sales Market Share Forecast by Type (2022-2027)
Table 107. Global Peramivir Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 108. Global Peramivir Revenue Market Share Forecast by Type (2022-2027)
Table 109. Global Peramivir Sales Forecast by Application (2022-2027) & (Kilotons)
Table 110. Global Peramivir Sales Market Share Forecast by Application (2022-2027)
Table 111. Global Peramivir Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 112. Global Peramivir Revenue Market Share Forecast by Application (2022-2027)
Table 113. Global Peramivir Sales Forecast by Region (2022-2027) & (Kilotons)
Table 114. Global Peramivir Sales Market Share Forecast by Region (2022-2027)
Table 115. Global Peramivir Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 116. Global Peramivir Revenue Market Share Forecast by Region (2022-2027)
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Peramivir
Figure 2. Global Peramivir Market Share by Type in 2020 & 2027
Figure 3. Solution Product Picture
Figure 4. Solid Product Picture
Figure 5. Global Peramivir Market Share by Application in 2020 & 2027
Figure 6. Influenza A Treatment
Figure 7. Influenza B Treatment
Figure 8. Global Peramivir Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Peramivir Market Size 2016-2027 (US$ Million)
Figure 10. Global Peramivir Sales 2016-2027 (Kilotons)
Figure 11. Global Peramivir Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Peramivir Sales Share by Manufacturers in 2020
Figure 13. Global Peramivir Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Peramivir Players: Market Share by Revenue in 2020
Figure 15. Peramivir Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Peramivir Sales Market Share by Region (2016-2021)
Figure 17. Global Peramivir Sales Market Share by Region in 2020
Figure 18. Global Peramivir Revenue Market Share by Region (2016-2021)
Figure 19. Global Peramivir Revenue Market Share by Region in 2020
Figure 20. U.S. Peramivir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Peramivir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Peramivir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Peramivir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Peramivir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Peramivir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Peramivir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Peramivir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Peramivir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Peramivir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Peramivir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Peramivir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Peramivir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Peramivir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Peramivir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Peramivir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Peramivir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Peramivir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Peramivir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Peramivir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Peramivir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Peramivir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Peramivir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Peramivir Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Peramivir by Type (2016-2021)
Figure 45. Sales Market Share of Peramivir by Application (2016-2021)
Figure 46. Sales Market Share of Peramivir by Application in 2020
Figure 47. Revenue Share of Peramivir by Application (2016-2021)
Figure 48. Revenue Share of Peramivir by Application in 2020
Figure 49. Manufacturing Cost Structure of Peramivir
Figure 50. Manufacturing Process Analysis of Peramivir
Figure 51. Peramivir Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed